We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$6.62B
AUM Growth
+$177M
Cap. Flow
-$113M
Cap. Flow %
-1.71%
Top 10 Hldgs %
15.47%
Holding
879
New
57
Increased
333
Reduced
336
Closed
64

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$33.1M
2
AVA icon
Avista
AVA
+$21.5M
3
MGLN
Magellan Health Services, Inc.
MGLN
+$13.7M
4
ABT icon
Abbott
ABT
+$12.8M
5
ALE
Allete
ALE
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.55%
2 Technology 16.34%
3 Financials 14.72%
4 Industrials 10.4%
5 Consumer Discretionary 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
301
Labcorp
LH
$25.8B
$4.18M 0.06%
28,148
-6,077
-18% -$848K
SYK icon
302
Stryker
SYK
$133B
$4.15M 0.06%
20,192
+233
+1% +$44.5K
SLYV icon
303
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.94B
$4.14M 0.06%
68,386
+1,359
+2% +$82.4K
JELD icon
304
JELD-WEN Holding
JELD
$98.2M
$4.11M 0.06%
193,666
+3,924
+2% +$79.1K
PSX icon
305
Phillips 66
PSX
$82.5B
$4.08M 0.06%
43,600
+91
+0.2% +$8.16K
HOLX
306
DELISTED
Hologic
HOLX
$4.07M 0.06%
84,695
-3,403
-4% -$157K
EMN icon
307
Eastman Chemical
EMN
$7.79B
$4.05M 0.06%
51,989
+1,110
+2% +$84.3K
FARO
308
DELISTED
Faro Technologies
FARO
$3.97M 0.06%
+75,425
New +$3.81M
TSM icon
309
TSMC
TSM
$2.03T
$3.95M 0.06%
100,903
-2,857
-3% -$118K
POR icon
310
Portland General Electric
POR
$5.92B
$3.87M 0.06%
71,385
-103,735
-59% -$5.49M
BIIB icon
311
Biogen
BIIB
$30.4B
$3.87M 0.06%
16,532
+2,037
+14% +$470K
PPC icon
312
Pilgrim's Pride
PPC
$7.09B
$3.83M 0.06%
151,017
-38,406
-20% -$994K
HZNP
313
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.82M 0.06%
158,870
+7,389
+5% +$187K
NTUS
314
DELISTED
Natus Medical Inc
NTUS
$3.68M 0.06%
143,251
+18,495
+15% +$471K
DOW icon
315
Dow Inc
DOW
$20.8B
$3.66M 0.06%
+74,391
New +$3.93M
GIS icon
316
General Mills
GIS
$20.1B
$3.63M 0.05%
68,876
-7,856
-10% -$406K
ASTE icon
317
Astec Industries
ASTE
$1.26B
$3.59M 0.05%
110,128
+27,508
+33% +$923K
IDU icon
318
iShares US Utilities ETF
IDU
$1.39B
$3.54M 0.05%
+46,900
New +$3.48M
VOO icon
319
Vanguard S&P 500 ETF
VOO
$971B
$3.51M 0.05%
13,051
+379
+3% +$100K
LMT icon
320
Lockheed Martin
LMT
$134B
$3.48M 0.05%
9,570
+6,556
+218% +$2.19M
IDXX icon
321
Idexx Laboratories
IDXX
$44.9B
$3.43M 0.05%
12,439
-1,037
-8% -$256K
IWR icon
322
iShares Russell Mid-Cap ETF
IWR
$56.5B
$3.42M 0.05%
61,239
+915
+2% +$50.2K
IWN icon
323
iShares Russell 2000 Value ETF
IWN
$14.5B
$3.41M 0.05%
28,420
+1,504
+6% +$182K
WK icon
324
Workiva
WK
$3.28B
$3.35M 0.05%
+57,666
New +$3.09M
IGSB icon
325
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$3.32M 0.05%
62,218
-81
-0.1% -$4.28K

Similar funds

Segall Bryant & Hamill's Q2 2019 Portfolio in Review

As of Q2 2019, Segall Bryant & Hamill held 879 positions worth $6.62B, up 2.7% from $6.44B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2019 filing shows 57 new, 333 increased, 336 reduced and 64 closed positions. Its largest new stake was Alcon: 564,559 shares worth $35M. The largest sale was LKQ Corp, an estimated $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Segall Bryant & Hamill's largest Q2 2019 buy was Alcon: 564,559 shares worth $35M.
  • Segall Bryant & Hamill added most to Magellan Health Services, Inc. in Q2 2019, an estimated $13.7M increase.
  • Segall Bryant & Hamill's biggest Q2 2019 reduction was LKQ Corp, cutting an estimated $21.2M.
  • Segall Bryant & Hamill fully exited The GEO Group in Q2 2019, selling an estimated $13.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $6.62B portfolio in Q2 2019.
  • Segall Bryant & Hamill opened 57 new positions and closed 64 in Q2 2019.
  • Segall Bryant & Hamill's portfolio value rose 2.7% quarter-over-quarter to $6.62B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2019, filed 14 Aug 2019.